Investor Commodore Capital Lp
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Commodore Capital Lp . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-08-15 13G ASMB / Assembly Biosciences, Inc. 1,615,981
2025-08-14 13G/A NGNE / Neurogene Inc. 800,000 427,866
2025-08-14 13G/A RLAY / Relay Therapeutics, Inc. 10,000,000 13,350,000
2025-08-14 13G COGT / Cogent Biosciences, Inc. 10,497,990 6,408,060
2025-08-14 13G/A SLDB / Solid Biosciences Inc. 5,825,000 0
2025-08-14 13G/A CRDF / Cardiff Oncology, Inc. 5,384,616 0
2025-08-14 13G/A ELVN / Enliven Therapeutics, Inc. 4,100,000 6,022,957
2025-08-14 13G/A MRUS / Merus N.V. 3,750,000 3,525,000
2025-08-14 13G/A COGT / Cogent Biosciences, Inc. 10,497,990 5,269,224
2025-07-02 13G CDTX / Cidara Therapeutics, Inc. 1,175,000
2025-05-15 13G RLAY / Relay Therapeutics, Inc. 10,000,000
2025-05-14 13G TYRA / Tyra Biosciences, Inc. 2,750,000
2025-04-11 13G VRDN / Viridian Therapeutics, Inc. 1,924,074 4,300,000
2025-04-10 13G CLDX / Celldex Therapeutics, Inc. 3,350,000
2025-02-25 13G SLDB / Solid Biosciences Inc. 5,825,000
2025-02-14 13G/A NKTX / Nkarta, Inc. 4,662,073 351,848
2025-02-14 13G/A CELC / Celcuity Inc. 2,217,982 1,095,650
2025-02-14 13G/A CELC / Celcuity Inc. 2,217,982 1,095,650
2025-02-14 13G/A DRUG / Bright Minds Biosciences Inc. 400,000 500,000
2025-02-14 13G NRIX / Nurix Therapeutics, Inc. 3,850,000
2025-02-14 13G/A NKTX / Nkarta, Inc. 4,662,073 351,848
2024-12-17 13G CRDF / Cardiff Oncology, Inc. 5,384,616
2024-12-16 13G MRUS / Merus N.V. 3,350,000 3,750,000
2024-12-11 13G NGNE / Neurogene Inc. 800,000
2024-11-14 13G/A VERA / Vera Therapeutics, Inc. 5,450,000 2,475,000
2024-11-14 13G/A MRUS / Merus N.V. 4,747,373 3,350,000
2024-11-14 13G/A ACET / Adicet Bio, Inc. 4,250,000 0
2024-11-14 13G/A SYRE / Spyre Therapeutics, Inc. 1,934,084 1,988,084
2024-11-14 13G/A COGT / Cogent Biosciences, Inc. 6,172,086 10,497,990
2024-11-14 13G/A ADVM / Adverum Biotechnologies, Inc. 10,000,000 0
2024-11-14 13G/A NKTX / Nkarta, Inc. 2,730,000 4,662,073
2024-11-14 13G/A CATX / Perspective Therapeutics, Inc. 3,350,000
2024-11-14 13G/A CELC / Celcuity Inc. 2,492,886 2,217,982
2024-11-14 13G/A MNMD / Mind Medicine (MindMed) Inc. 5,833,333 8,176,721
2024-11-14 13G/A VERA / Vera Therapeutics, Inc. 5,450,000 3,900,000
2024-11-14 13G/A CCCC / C4 Therapeutics, Inc. 3,800,000 3,410,384
2024-11-14 13G/A ELVN / Enliven Therapeutics, Inc. 2,901,816 4,100,000
2024-10-25 13G DRUG / Bright Minds Biosciences Inc. 400,000
2024-10-17 13G IKT / Inhibikase Therapeutics, Inc. 6,807,507
2024-06-21 13G PCSC / Perceptive Capital Solutions Corp 750,000
2024-04-19 13G ISR / Perspective Therapeutics Inc 38,906,673
2024-03-21 13G MNMD / Mind Medicine (MindMed) Inc. 5,833,333
2024-02-14 13G/A VERA / Vera Therapeutics, Inc. 2,342,857 5,450,000
2024-02-14 13G/A CABA / Cabaletta Bio, Inc. 1,458,367 1,900,000
2024-02-14 13G/A CBAY / CymaBay Therapeutics, Inc. 5,738,500 0
2024-02-14 13G/A AMAM / Ambrx Biopharma Inc. 0
2024-02-14 13G/A MRUS / Merus N.V. 2,732,567 4,747,373
2024-02-14 13G/A CELC / Celcuity Inc. 2,257,412 2,492,886
2024-02-14 13G/A SLNO / Soleno Therapeutics, Inc. 885,741 700,000
2024-02-14 13G/A ADVM / Adverum Biotechnologies, Inc. 6,158,141 10,000,000
2024-02-14 13G/A COGT / Cogent Biosciences, Inc. 4,926,000 6,172,086
2024-02-14 13G/A IMUX / Immunic, Inc. 2,873,563 0
2024-02-14 13G/A VERA / Vera Therapeutics, Inc. 2,342,857 5,001,783
2024-02-14 13G/A ELVN / Enliven Therapeutics, Inc. 2,082,123 2,901,816
2024-02-14 13G/A VRDN / Viridian Therapeutics, Inc. 2,020,166 1,924,074
2024-02-14 13G/A SABS / SAB Biotherapeutics, Inc. 6,932,463 1,831,746
2024-02-14 13G/A SYRE / Spyre Therapeutics, Inc. 1,834,084 1,934,084
2024-01-19 13G ACET / Adicet Bio, Inc. 4,250,000
2023-12-22 13G CCCC / C4 Therapeutics, Inc. 3,800,000
2023-12-01 13G SYRE / Spyre Therapeutics, Inc. 1,834,084
2023-11-03 13G HARP / Harpoon Therapeutics, Inc. 1,703,465
2023-10-27 13G NKTX / Nkarta, Inc. 2,730,000
2023-10-16 13G SABS / SAB Biotherapeutics, Inc. 6,932,463
2023-10-12 13G SLNO / Soleno Therapeutics, Inc. 885,741
2023-10-06 13G/A VTGN / Vistagen Therapeutics, Inc. 1,575,000 2,367,884
2023-08-09 13G VTGN / Vistagen Therapeutics, Inc. 0 1,575,000
2023-04-27 13G/A AMAM / Ambrx Biopharma Inc. 35,700,000 31,181,983
2023-04-24 13G ELVN / Enliven Therapeutics, Inc. 1,448,640 2,082,123
2023-04-20 13G ADVM / Adverum Biotechnologies, Inc. 6,158,141
2023-03-30 13G BLU / Bellus Health Inc 5,303,557 6,579,359
2023-03-03 13G/A AMAM / Ambrx Biopharma Inc. 35,700,000
2023-03-03 13G AMAM / Ambrx Biopharma Inc. 26,250,000
2023-02-28 13G/A ELVN / Enliven Therapeutics, Inc. 1,448,640
2023-02-21 13G/A IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF 2,494,794 2,840,754
2023-02-16 13G VERA / Vera Therapeutics, Inc. 2,342,857
2023-02-14 13G/A VRDN / Viridian Therapeutics, Inc. 1,371,339 2,020,166
2023-02-14 13G/A IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF 1,497,910 2,494,794
2023-02-14 13G/A CBAY / CymaBay Therapeutics, Inc. 5,419,896 5,738,500
2023-02-14 13G/A CELC / Celcuity Inc. 920,464 2,257,412
2023-02-14 13G/A BLU / Bellus Health Inc 5,457,110 5,303,557
2023-02-14 13G/A KPTI / Karyopharm Therapeutics Inc. 4,011,052 1,935,609
2023-02-14 13G/A VTGN / Vistagen Therapeutics, Inc. 10,455,910 0
2023-02-14 13G/A COGT / Cogent Biosciences, Inc. 2,281,315 4,926,000
2023-02-14 13G/A MRUS / Merus N.V. 2,242,224 2,732,567
2023-02-14 13G/A IMUX / Immunic, Inc. 3,766,576 2,873,563
2023-01-13 13G CABA / Cabaletta Bio, Inc. 1,458,367
2022-11-16 13G/A STSA / Satsuma Pharmaceuticals Inc 3,711,286 0
2022-10-24 13G IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF 1,497,910
2022-10-21 13G IMUX / Immunic, Inc. 3,766,576
2022-05-19 13G VRDN / Viridian Therapeutics, Inc. 1,371,339
2022-05-16 13G MRUS / Merus N.V. 2,242,224
2022-05-09 13G KPTI / Karyopharm Therapeutics Inc. 4,011,052
2022-04-14 13G VTGN / Vistagen Therapeutics, Inc. 10,455,910
2022-02-14 13G/A STSA / Satsuma Pharmaceuticals Inc 3,208,761 3,711,286
2022-02-14 13G/A GNCA / Genocea Biosciences Inc 2,871,624 3,079,756
2022-02-14 13G/A COGT / Cogent Biosciences, Inc. 2,141,339 2,281,315
2022-02-14 13G/A CBAY / CymaBay Therapeutics, Inc. 3,529,465 5,419,896
2022-02-14 13G/A CELC / Celcuity Inc. 830,967 920,464
2022-02-14 13G BLU / Bellus Health Inc 5,457,110
2021-11-04 13G COGT / Cogent Biosciences, Inc. 2,141,339 2,141,339
2021-10-19 13G/A STSA / Satsuma Pharmaceuticals Inc 2,119,245 3,208,761
2021-07-12 13G CBAY / CymaBay Therapeutics, Inc. 3,529,465
2021-07-09 13G CELC / Celcuity Inc. 830,967
2021-03-31 13G GNCA / Genocea Biosciences Inc 2,871,624
2021-03-15 13G 859319303 / Sterling Financial Corp 2,119,245